Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
First, we discuss the CDC's about-face on mask wearing, the debate over vaccine booster shots, and the slow but steady race to develop pills for Covid-19. Then, STAT's Kate Sheridan joins us to discuss a setback in the field of microbiomics and the mounting skepticism over whether tinkering with gut bacteria can eventually treat a host of diseases. We also break down the latest fallout from the FDA's approval of Aduhelm, the sorry state of biotech stocks, and an in-development feature film about CRISPR.